Cargando…
The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
Cancer is one of the main causes of disease-related deaths in the world. Although cancer treatment strategies have been improved in recent years, the survival time of cancer patients is still far from satisfied. Cancer immunotherapy, such as Oncolytic virotherapy, Immune checkpoints inhibition, Chim...
Autores principales: | Wang, Luyao, Chen, Yurong, Liu, Xinrui, Li, Ziyi, Dai, Xiangpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801488/ https://www.ncbi.nlm.nih.gov/pubmed/35111663 http://dx.doi.org/10.3389/fonc.2021.704999 |
Ejemplares similares
-
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021) -
Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015) -
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023) -
Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology
por: Peng, Rongxue, et al.
Publicado: (2022) -
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
por: Rafii, Saeed, et al.
Publicado: (2022)